No Data
No Data
Prestige Consumer Healthcare to Release Fiscal 2025 First Quarter Earnings Results
PDF VersionTARRYTOWN, N.Y., July 02, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2025 first quarter earnings release on Thursd
This Nike Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings pag
Express News | Prestige Consumer Healthcare Inc : D.a. Davidson Raises to Buy From Neutral
DA Davidson Upgrades Prestige Consumer Healthcare to Buy From Neutral, Adjusts Price Target to $93 From $65
Prestige Consumer Healthcare (PBH) has an average rating of outperform and price targets ranging from $65 to $81, according to analysts polled by Capital IQ.
D.A. Davidson Upgrades Prestige Consumer Healthcare(PBH.US) to Buy Rating, Announces Target Price $93
D.A. Davidson analyst Linda Bolton Weiser upgrades $Prestige Consumer Healthcare(PBH.US)$ to a buy rating, and sets the target price at $93.According to TipRanks data, the analyst has a success rate o
Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Business Is Trailing The Industry But Its Shares Aren't
It's not a stretch to say that Prestige Consumer Healthcare Inc.'s (NYSE:PBH) price-to-sales (or "P/S") ratio of 2.9x right now seems quite "middle-of-the-road" for companies in the Pharmaceuticals i